Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): A phase 3, double-blind, randomised, multicentre, placebo-controlled trial
This is especially helpful for people with type 2 diabetes, but it also benefits those who are trying to lose weight by keeping blood sugar levels stable
Lab Report Date Added : 07/31/2026 Description Additional information Reconstitution Info Reviews (0) Semaglutide for Sale Research-Grade, ADS-tested Looking to buy Semaglutide
Pull back the plunger to draw your predetermined amount
US$ 26.71
US$ 23.46
US$ 27.15
US$ 24.58
US$ 27.91
US$ 26.31
US$ 20.03
US$ 24.61
